Interim Report January-June 2016

Oriola-KD Corporation published the interim report 1 January - 30 June 2016 on Tuesday, 19 July 2016 at 8.30 a.m.

President and CEO Eero Hautaniemi's comments regarding the interim report:

​"The first half of 2016 went in line with our expectations. In Consumer business our growth continued to be slightly below market, but the sales mix developed favorably supporting the profitability. In Q2 we succeeded well with the sales of seasonal products. In Services business volumes continued to be at good level and we completed the closure of Oulu distribution center as planned. Healthcare business was somewhat burdened with start-up costs related to hospital and veterinarian businesses but dose dispensing business performed according to plans. July 18 announced acquisition of Pharmaservice Oy in Finland makes Oriola-KD a leading dose dispensing company in our main markets Sweden and Finland and is an important step in our way to build the third business area, Healthcare."